Phase 1 Chronic Fatigue Syndrome Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

Chronic Fatigue SyndromeHealthyMultiple Sclerosis+1 more

University of Alabama at Birmingham120 enrolled1 locationNCT03759522

Not Yet Recruiting

Phase 1

Testing the Safety and Effects of the Psychedelic Psilocin on Wellbeing and Anxiety in People with Ongoing Physical and Mental Health Conditions

Chronic Fatigue SyndromeAnorexia NervosaFibromyalgia+6 more

Tryptamine Therapeutics66 enrolled1 locationACTRN12625000949482

Not Yet Recruiting

Phase 1

low dose naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long coronavirus disease (long COVID) symptoms

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Long COVID

Griffith University56 enrolled1 locationACTRN12624001162505